Sarepta Therapeutics, Inc. (FRA:AB3A)

Sarepta Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,147	11,218	8,161	10,643	6,895	10,999
Market Cap Growth	-80.63%	37.46%	-23.32%	54.37%	-37.31%	28.32%
Enterprise Value	2,499	11,427	7,850	10,205	6,524	10,155
Last Close Price	19.62	115.95	88.08	118.56	80.06	139.32
PE Ratio	-	49.37	-	-	-	-
PS Ratio	1.04	6.11	7.26	12.19	11.17	24.91
PB Ratio	1.91	7.60	10.50	29.55	8.45	17.66
P/TBV Ratio	1.95	7.74	10.87	30.14	8.58	17.98
P/FCF Ratio	-	-	-	-	-	532.53
P/OCF Ratio	-	-	-	-	-	125.19
EV/Sales Ratio	1.20	6.22	6.98	11.69	10.57	23.00
EV/EBITDA Ratio	30.97	46.25	-	-	-	-
EV/EBIT Ratio	-	54.25	-	-	-	-
EV/FCF Ratio	-7.69	-	-	-	-	491.69
Debt / Equity Ratio	0.96	0.88	1.61	4.20	1.23	1.41
Debt / EBITDA Ratio	13.43	3.74	-	-	-	-
Debt / FCF Ratio	-	-	-	-	-	42.47
Asset Turnover	0.68	0.53	0.39	0.30	0.23	0.23
Inventory Turnover	2.40	2.10	3.90	5.21	4.12	3.90
Quick Ratio	1.51	2.74	3.23	3.63	5.05	4.99
Current Ratio	2.95	4.20	3.95	4.13	5.75	5.97
Return on Equity (ROE)	-21.37%	19.71%	-86.15%	-107.16%	-49.57%	-70.14%
Return on Assets (ROA)	-1.52%	3.77%	-5.24%	-10.68%	-9.04%	-14.67%
Return on Capital (ROIC)	-2.06%	5.34%	-7.90%	-16.47%	-14.21%	-20.84%
Return on Capital Employed (ROCE)	-3.30%	6.70%	-10.30%	-21.40%	-16.50%	-22.00%
Earnings Yield	-10.78%	2.02%	-5.94%	-6.19%	-5.34%	-4.12%
FCF Yield	-15.13%	-2.95%	-6.40%	-3.13%	-6.14%	0.19%
Buyback Yield / Dilution	2.62%	-16.75%	-5.53%	-7.75%	-4.24%	-5.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.